Worsley Stephen 4
4 · SUTRO BIOPHARMA, INC. · Filed Jan 31, 2019
Insider Transaction Report
Form 4
Worsley Stephen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy Common Stock)
2019-01-29+30,000→ 30,000 totalExercise: $10.45Exp: 2029-01-28→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, beginning on February 28, 2019, with 100% of the total shares vested and exercisable on January 29, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.